Industry: Medical Devices & Consumables
Published Date: 2026-07-11
Pages: 128 Pages
Report ld: 5558822
Request Sample
Customized Report
Cardiopulmonary Bypass Equipment Market Size(US$)

CAGR 2026-2032
9.7%
Market Size,2032
USD 1,042
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
The global Cardiopulmonary Bypass Equipment market size was US$ 550 million in 2025 and is forecast to reach a readjusted size of US$ 1042 million by 2032 with a CAGR of 9.7% during the forecast period 2026-2032.
Cardiopulmonary Bypass Equipment refers to a life-support system designed to temporarily replace or assist the pumping function of the heart and the gas-exchange function of the lungs during open-heart and selected major vascular procedures. Its central component is generally a heart-lung machine, which removes venous blood from the patient, pumps it through an oxygenator for oxygenation and carbon-dioxide removal, and returns it to the arterial circulation. This process maintains systemic perfusion while the heart is stopped or blood flow is interrupted. A complete system typically includes roller or centrifugal pumps, a central control console, monitoring modules, heater-cooler units and gas-blending devices, operating together with disposable oxygenators, reservoirs, tubing sets, cannulae and filters. The equipment is primarily used in coronary artery bypass grafting, valve repair or replacement, congenital heart surgery, aortic procedures and cardiopulmonary transplantation. It must provide highly reliable control of blood flow, temperature, pressure, air detection, patient monitoring and procedural data.In 2025, global Cardiopulmonary Bypass Equipment production reached approximately 2000 units.The average gross profit margin of this product is 55%.
Population aging, the increasing prevalence of coronary and valvular heart disease, and the expansion of complex cardiac surgery into more regional medical centers are supporting sustained demand for cardiopulmonary bypass equipment. Although interventional and minimally invasive therapies are replacing surgery in selected patients, complex coronary lesions, multivalvular disease, congenital defects and major aortic disorders still require extracorporeal circulation. Hospitals are also replacing aging heart-lung machines and shifting purchasing priorities from basic pumping capability toward integrated monitoring, automated safety control and digital perfusion management. Embedded patient monitoring, advanced sensors and procedural data integration are extending product value from capital equipment into consumables, software, maintenance and clinical services.
Because cardiopulmonary bypass equipment directly supports blood circulation, failures involving pump speed, air management, temperature control or monitoring can have severe clinical consequences. Manufacturers must therefore complete extensive testing covering biocompatibility, mechanical integrity, blood damage, air entrapment, reliability and sterilization, while managing lengthy regulatory and hospital-approval processes. High acquisition costs, complex cardiac-surgery training requirements and shortages of qualified perfusion personnel can constrain adoption in smaller hospitals. Product recalls and component shortages may also damage customer confidence, making robust quality systems, preventive maintenance and responsive technical support essential competitive requirements.
Downstream purchasing is shifting from standalone heart-lung machines toward integrated combinations of equipment, disposables, clinical data and services. Major cardiac centers increasingly require real-time monitoring of flow, pressure, temperature, blood gases and reservoir levels, together with connectivity to hospital information systems. Pediatric cardiac programs place additional emphasis on low-prime circuits and precise flow control to reduce hemodilution and blood trauma. Standardized interfaces, automated warnings, electronic case documentation, remote diagnostics and clinical training are also becoming more important. Systems that simplify operation and improve consistency between perfusion teams are therefore likely to capture stronger replacement demand.
The global Cardiopulmonary Bypass Equipment market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on sales, revenue, and forecasts across regions, by Type, and by Application for 2021-2032.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Report scope, segment-level executive summary (by Type, by Application) and market evolution across the short, mid and long term
Chapter 2: Quantitative analysis of Cardiopulmonary Bypass Equipment sales and revenue at global, regional, and country levels, highlighting market size and growth potential by region
Chapter 3: Competitive landscape of Cardiopulmonary Bypass Equipment manufacturers (sales, revenue, pricing, market share, industry rankings, and M&A / expansion plans)
Chapter 4: by Type-based segmentation analysis (sales, revenue, pricing, and growth potential) to identify blue-ocean product segments
Chapter 5: by Application-based segmentation analysis (sales, revenue, pricing, and growth potential) to uncover high-value downstream markets
Chapter 6: Regional breakdown by company, customer, by Type and by Application (sales, revenue, and pricing for each segment)
Chapter 7: Key manufacturer profiles –company overview, Cardiopulmonary Bypass Equipment product descriptions and specifications, revenue, gross margins, and recent developments
Chapter 8: Industry chain analysis – upstream raw materials, manufacturing links, and downstream application sectors
Chapter 9: Sales channels and distributor analysis – routes to market and key customer interfaces
Chapter 10: Market dynamics – trends, drivers, restraints, risks for manufacturers, and the impact of relevant industry policies
Chapter 11: Key findings, main takeaways, and overall conclusions of the report.
WHY THIS REPORT
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Cardiopulmonary Bypass Equipment value chain, addressing:
- Market entry risks/opportunities by region
- Product mix optimization based on local practices
- Competitor tactics in fragmented vs. consolidated markets
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Market Overview
1.1 Cardiopulmonary Bypass Equipment Product Scope
1.2 Cardiopulmonary Bypass Equipment by Type
1.2.1 Global Cardiopulmonary Bypass Equipment Sales by Type (2021, 2025 & 2032)
1.2.2 Single Roller Pump Cardiopulmonary Bypass Equipment
1.2.3 Double Roller Pump Cardiopulmonary Bypass Equipment
1.3 Cardiopulmonary Bypass Equipment by Application
1.3.1 Global Cardiopulmonary Bypass Equipment Sales Comparison by Application (2021, 2025 & 2032)
1.3.2 Cardiac Surgery
1.3.3 Lung Transplant Operation
1.3.4 Acute Respiratory Failure Treatment
1.3.5 Others
1.4 Global Cardiopulmonary Bypass Equipment Market Estimates and Forecasts (2021-2032)
1.4.1 Global Cardiopulmonary Bypass Equipment Market Size (Value) and Growth Rate (2021-2032)
1.4.2 Global Cardiopulmonary Bypass Equipment Market Size (Volume) and Growth Rate (2021-2032)
1.4.3 Global Cardiopulmonary Bypass Equipment Price Trends (2021-2032)
1.5 Assumptions and Limitations
2 Market Size and Prospects by Region
2.1 Global Cardiopulmonary Bypass Equipment Market Size by Region: 2021 VS 2025 VS 2032
2.2 Global Cardiopulmonary Bypass Equipment Historical Market Scenario by Region (2021-2026)
2.2.1 Global Cardiopulmonary Bypass Equipment Sales Market Share by Region (2021-2026)
2.2.2 Global Cardiopulmonary Bypass Equipment Revenue Market Share by Region (2021-2026)
2.3 Global Cardiopulmonary Bypass Equipment Market Estimates and Forecasts by Region (2027-2032)
2.3.1 Global Cardiopulmonary Bypass Equipment Sales Estimates and Forecasts by Region (2027-2032)
2.3.2 Global Cardiopulmonary Bypass Equipment Revenue Forecast by Region (2027-2032)
2.4 Major Regions and Emerging Market Analysis
2.4.1 North America Cardiopulmonary Bypass Equipment Market Size and Prospects (2021-2032)
2.4.2 Europe Cardiopulmonary Bypass Equipment Market Size and Prospects (2021-2032)
2.4.3 China Cardiopulmonary Bypass Equipment Market Size and Prospects (2021-2032)
2.4.4 Japan Cardiopulmonary Bypass Equipment Market Size and Prospects (2021-2032)
2.4.5 Latin America Cardiopulmonary Bypass Equipment Market Size and Prospects (2021-2032)
3 Global Market Size by Type
3.1 Global Cardiopulmonary Bypass Equipment Historical Market Review by Type (2021-2026)
3.1.1 Global Cardiopulmonary Bypass Equipment Sales by Type (2021-2026)
3.1.2 Global Cardiopulmonary Bypass Equipment Revenue by Type (2021-2026)
3.1.3 Global Cardiopulmonary Bypass Equipment Average Price by Type (2021-2026)
3.2 Global Cardiopulmonary Bypass Equipment Market Estimates and Forecasts by Type (2027-2032)
3.2.1 Global Cardiopulmonary Bypass Equipment Sales Forecast by Type (2027-2032)
3.2.2 Global Cardiopulmonary Bypass Equipment Revenue Forecast by Type (2027-2032)
3.2.3 Global Cardiopulmonary Bypass Equipment Price Forecast by Type (2027-2032)
3.3 Representative Players for Different Types of Cardiopulmonary Bypass Equipment
4 Global Market Size by Application
4.1 Global Cardiopulmonary Bypass Equipment Historical Market Review by Application (2021-2026)
4.1.1 Global Cardiopulmonary Bypass Equipment Sales by Application (2021-2026)
4.1.2 Global Cardiopulmonary Bypass Equipment Revenue by Application (2021-2026)
4.1.3 Global Cardiopulmonary Bypass Equipment Average Price by Application (2021-2026)
4.2 Global Cardiopulmonary Bypass Equipment Market Estimates and Forecasts by Application (2027-2032)
4.2.1 Global Cardiopulmonary Bypass Equipment Sales Forecast by Application (2027-2032)
4.2.2 Global Cardiopulmonary Bypass Equipment Revenue Forecast by Application (2027-2032)
4.2.3 Global Cardiopulmonary Bypass Equipment Price Forecast by Application (2027-2032)
4.3 New Sources of Growth in Cardiopulmonary Bypass Equipment Applications
5 Competition Landscape by Players
5.1 Global Cardiopulmonary Bypass Equipment Sales by Player (2021-2026)
5.2 Global Top Cardiopulmonary Bypass Equipment Players by Revenue (2021-2026)
5.3 Global Cardiopulmonary Bypass Equipment Market Share by Company Type (Tier 1, Tier 2, and Tier 3), based on Cardiopulmonary Bypass Equipment revenue as of 2025
5.4 Global Cardiopulmonary Bypass Equipment Average Price by Company (2021-2026)
5.5 Global Key Manufacturers of Cardiopulmonary Bypass Equipment, Manufacturing Sites & Headquarters
5.6 Global Key Manufacturers of Cardiopulmonary Bypass Equipment, Product Type & Application
5.7 Global Key Manufacturers of Cardiopulmonary Bypass Equipment, Date of Entry into This Industry
5.8 Manufacturers Mergers & Acquisitions, Expansion Plans
6 Regional Analysis
6.1 North America Market: Players, Segments, Downstream and Major Customers
6.1.1 North America Cardiopulmonary Bypass Equipment Sales by Company
6.1.1.1 North America Cardiopulmonary Bypass Equipment Sales by Company (2021-2026)
6.1.1.2 North America Cardiopulmonary Bypass Equipment Revenue by Company (2021-2026)
6.1.2 North America Cardiopulmonary Bypass Equipment Sales Breakdown by Type (2021-2026)
6.1.3 North America Cardiopulmonary Bypass Equipment Sales Breakdown by Application (2021-2026)
6.1.4 North America Cardiopulmonary Bypass Equipment Major Customers
6.1.5 North America Market Trends and Opportunities
6.2 Europe Market: Players, Segments, Downstream and Major Customers
6.2.1 Europe Cardiopulmonary Bypass Equipment Sales by Company
6.2.1.1 Europe Cardiopulmonary Bypass Equipment Sales by Company (2021-2026)
6.2.1.2 Europe Cardiopulmonary Bypass Equipment Revenue by Company (2021-2026)
6.2.2 Europe Cardiopulmonary Bypass Equipment Sales Breakdown by Type (2021-2026)
6.2.3 Europe Cardiopulmonary Bypass Equipment Sales Breakdown by Application (2021-2026)
6.2.4 Europe Cardiopulmonary Bypass Equipment Major Customers
6.2.5 Europe Market Trends and Opportunities
6.3 China Market: Players, Segments, Downstream and Major Customers
6.3.1 China Cardiopulmonary Bypass Equipment Sales by Company
6.3.1.1 China Cardiopulmonary Bypass Equipment Sales by Company (2021-2026)
6.3.1.2 China Cardiopulmonary Bypass Equipment Revenue by Company (2021-2026)
6.3.2 China Cardiopulmonary Bypass Equipment Sales Breakdown by Type (2021-2026)
6.3.3 China Cardiopulmonary Bypass Equipment Sales Breakdown by Application (2021-2026)
6.3.4 China Cardiopulmonary Bypass Equipment Major Customers
6.3.5 China Market Trends and Opportunities
6.4 Japan Market: Players, Segments, Downstream and Major Customers
6.4.1 Japan Cardiopulmonary Bypass Equipment Sales by Company
6.4.1.1 Japan Cardiopulmonary Bypass Equipment Sales by Company (2021-2026)
6.4.1.2 Japan Cardiopulmonary Bypass Equipment Revenue by Company (2021-2026)
6.4.2 Japan Cardiopulmonary Bypass Equipment Sales Breakdown by Type (2021-2026)
6.4.3 Japan Cardiopulmonary Bypass Equipment Sales Breakdown by Application (2021-2026)
6.4.4 Japan Cardiopulmonary Bypass Equipment Major Customers
6.4.5 Japan Market Trends and Opportunities
6.5 Latin America Market: Players, Segments, Downstream and Major Customers
6.5.1 Latin America Cardiopulmonary Bypass Equipment Sales by Company
6.5.1.1 Latin America Cardiopulmonary Bypass Equipment Sales by Company (2021-2026)
6.5.1.2 Latin America Cardiopulmonary Bypass Equipment Revenue by Company (2021-2026)
6.5.2 Latin America Cardiopulmonary Bypass Equipment Sales Breakdown by Type (2021-2026)
6.5.3 Latin America Cardiopulmonary Bypass Equipment Sales Breakdown by Application (2021-2026)
6.5.4 Latin America Cardiopulmonary Bypass Equipment Major Customers
6.5.5 Latin America Market Trends and Opportunities
7 Company Profiles and Key Figures
7.1 Sorin Group
7.1.1 Sorin Group Company Information
7.1.2 Sorin Group Business Overview
7.1.3 Sorin Group Cardiopulmonary Bypass Equipment Sales, Revenue and Gross Margin (2021-2026)
7.1.4 Sorin Group Cardiopulmonary Bypass Equipment Products Offered
7.1.5 Sorin Group Recent Development
7.2 LivaNova
7.2.1 LivaNova Company Information
7.2.2 LivaNova Business Overview
7.2.3 LivaNova Cardiopulmonary Bypass Equipment Sales, Revenue and Gross Margin (2021-2026)
7.2.4 LivaNova Cardiopulmonary Bypass Equipment Products Offered
7.2.5 LivaNova Recent Development
7.3 Medtronic
7.3.1 Medtronic Company Information
7.3.2 Medtronic Business Overview
7.3.3 Medtronic Cardiopulmonary Bypass Equipment Sales, Revenue and Gross Margin (2021-2026)
7.3.4 Medtronic Cardiopulmonary Bypass Equipment Products Offered
7.3.5 Medtronic Recent Development
7.4 Terumo Cardiovascular
7.4.1 Terumo Cardiovascular Company Information
7.4.2 Terumo Cardiovascular Business Overview
7.4.3 Terumo Cardiovascular Cardiopulmonary Bypass Equipment Sales, Revenue and Gross Margin (2021-2026)
7.4.4 Terumo Cardiovascular Cardiopulmonary Bypass Equipment Products Offered
7.4.5 Terumo Cardiovascular Recent Development
7.5 Fresenius Medical Care
7.5.1 Fresenius Medical Care Company Information
7.5.2 Fresenius Medical Care Business Overview
7.5.3 Fresenius Medical Care Cardiopulmonary Bypass Equipment Sales, Revenue and Gross Margin (2021-2026)
7.5.4 Fresenius Medical Care Cardiopulmonary Bypass Equipment Products Offered
7.5.5 Fresenius Medical Care Recent Development
7.6 Getinge
7.6.1 Getinge Company Information
7.6.2 Getinge Business Overview
7.6.3 Getinge Cardiopulmonary Bypass Equipment Sales, Revenue and Gross Margin (2021-2026)
7.6.4 Getinge Cardiopulmonary Bypass Equipment Products Offered
7.6.5 Getinge Recent Development
7.7 Braile Biomedica
7.7.1 Braile Biomedica Company Information
7.7.2 Braile Biomedica Business Overview
7.7.3 Braile Biomedica Cardiopulmonary Bypass Equipment Sales, Revenue and Gross Margin (2021-2026)
7.7.4 Braile Biomedica Cardiopulmonary Bypass Equipment Products Offered
7.7.5 Braile Biomedica Recent Development
7.8 Chalice Medical
7.8.1 Chalice Medical Company Information
7.8.2 Chalice Medical Business Overview
7.8.3 Chalice Medical Cardiopulmonary Bypass Equipment Sales, Revenue and Gross Margin (2021-2026)
7.8.4 Chalice Medical Cardiopulmonary Bypass Equipment Products Offered
7.8.5 Chalice Medical Recent Development
7.9 Tianjin Medical
7.9.1 Tianjin Medical Company Information
7.9.2 Tianjin Medical Business Overview
7.9.3 Tianjin Medical Cardiopulmonary Bypass Equipment Sales, Revenue and Gross Margin (2021-2026)
7.9.4 Tianjin Medical Cardiopulmonary Bypass Equipment Products Offered
7.9.5 Tianjin Medical Recent Development
8 Cardiopulmonary Bypass Equipment Manufacturing Cost Analysis
8.1 Cardiopulmonary Bypass Equipment Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Key Suppliers of Raw Materials
8.2 Manufacturing Cost Structure
8.3 Manufacturing Process Analysis of Cardiopulmonary Bypass Equipment
8.4 Cardiopulmonary Bypass Equipment Industrial Chain Analysis
9 Marketing Channels, Distributors and Customers
9.1 Marketing Channels
9.2 Cardiopulmonary Bypass Equipment Distributors List
9.3 Cardiopulmonary Bypass Equipment Customers
10 Cardiopulmonary Bypass Equipment Market Dynamics
10.1 Cardiopulmonary Bypass Equipment Industry Trends
10.2 Cardiopulmonary Bypass Equipment Market Drivers
10.3 Cardiopulmonary Bypass Equipment Market Challenges
10.4 Cardiopulmonary Bypass Equipment Market Restraints
11 Research Findings and Conclusion
12 Appendix
12.1 Research Methodology
12.1.1 Methodology/Research Approach
12.1.1.1 Research Programs/Design
12.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
12.1.2 Data Source
12.1.2.1 Secondary Sources
12.1.2.2 Primary Sources
12.2 Author Details
12.3 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global Cardiopulmonary Bypass Equipment market is projected to grow from US$ 550 million in 2025 to US$ 1042 million by 2032, at a CAGR of 9.7% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2026-07-11
Pages: 139
USD 4900.00
(Single User License)
The global Cardiopulmonary Bypass Equipment market was valued at US$ 550 million in 2025 and is anticipated to reach US$ 1042 million by 2032, at a CAGR of 9.7% from 2026 to 2032.
Published Date: 2026-07-11
Pages: 114
USD 2900.00
(Single User License)
The global market for Cardiopulmonary Bypass Equipment was estimated to be worth US$ 550 million in 2025 and is projected to reach US$ 1042 million, growing at a CAGR of 9.7% from 2026 to 2032.
Published Date: 2026-07-11
Pages: 132
USD 3950.00
(Single User License)
The global Cardiopulmonary Bypass Equipment market is projected to grow from US$ 506 million in 2024 to US$ 959 million by 2031, at a CAGR of 9.7% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-09-11
Pages: 135
USD 4900.00
(Single User License)
In 2024, the global market size of Cardiopulmonary Bypass Equipment was estimated to be worth US$ 506 million and is forecast to reach approximately US$ 959 million by 2031 with a CAGR of 9.7% during the forecast period 2025-2031.
Published Date: 2025-03-28
Pages: 123
USD 5900.00
(Single User License)
The global Cardiopulmonary Bypass Equipment market size was US$ 506 million in 2024 and is forecast to a readjusted size of US$ 959 million by 2031 with a CAGR of 9.7% during the forecast period 2025-2031.
Published Date: 2025-03-19
Pages: 77
USD 4250.00
(Single User License)
The global market for Cardiopulmonary Bypass Equipment was estimated to be worth US$ 506 million in 2024 and is forecast to a readjusted size of US$ 959 million by 2031 with a CAGR of 9.7% during the forecast period 2025-2031.
Published Date: 2025-01-16
Pages: 109
USD 3950.00
(Single User License)
The global market for Cardiopulmonary Bypass Equipment was valued at US$ 506 million in the year 2024 and is projected to reach a revised size of US$ 959 million by 2031, growing at a CAGR of 9.7% during the forecast period.
Published Date: 2025-01-16
Pages: 83
USD 2900.00
(Single User License)
Cardiopulmonary Bypass Equipment is a device used in open heart surgery to support the body during the surgical procedure while the heart is stopped. The Cardiopulmonary Bypass Equipment is also called a heart-lung machine. The heart-lung machine is often referred to as the “pump”, and does the work of the heart and lungs during the operation.
Published Date: 2024-04-17
Pages: 146
USD 5600.00
(Single User License)
Cardiopulmonary Bypass Equipment is a device used in open heart surgery to support the body during the surgical procedure while the heart is stopped. The Cardiopulmonary Bypass Equipment is also called a heart-lung machine. The heart-lung machine is often referred to as the “pump”, and does the work of the heart and lungs during the operation.
Published Date: 2024-04-16
Pages: 123
USD 5900.00
(Single User License)
The global Cardiopulmonary Bypass Equipment market is projected to grow from US$ 550 million in 2025 to US$ 1042 million by 2032, at a CAGR of 9.7% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2026-07-11
Pages: 139
The global Cardiopulmonary Bypass Equipment market was valued at US$ 550 million in 2025 and is anticipated to reach US$ 1042 million by 2032, at a CAGR of 9.7% from 2026 to 2032.
Published: 2026-07-11
Pages: 114
The global market for Cardiopulmonary Bypass Equipment was estimated to be worth US$ 550 million in 2025 and is projected to reach US$ 1042 million, growing at a CAGR of 9.7% from 2026 to 2032.
Published: 2026-07-11
Pages: 132
The global Cardiopulmonary Bypass Equipment market is projected to grow from US$ 506 million in 2024 to US$ 959 million by 2031, at a CAGR of 9.7% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-09-11
Pages: 135
In 2024, the global market size of Cardiopulmonary Bypass Equipment was estimated to be worth US$ 506 million and is forecast to reach approximately US$ 959 million by 2031 with a CAGR of 9.7% during the forecast period 2025-2031.
Published: 2025-03-28
Pages: 123
The global Cardiopulmonary Bypass Equipment market size was US$ 506 million in 2024 and is forecast to a readjusted size of US$ 959 million by 2031 with a CAGR of 9.7% during the forecast period 2025-2031.
Published: 2025-03-19
Pages: 77
The global market for Cardiopulmonary Bypass Equipment was estimated to be worth US$ 506 million in 2024 and is forecast to a readjusted size of US$ 959 million by 2031 with a CAGR of 9.7% during the forecast period 2025-2031.
Published: 2025-01-16
Pages: 109
The global market for Cardiopulmonary Bypass Equipment was valued at US$ 506 million in the year 2024 and is projected to reach a revised size of US$ 959 million by 2031, growing at a CAGR of 9.7% during the forecast period.
Published: 2025-01-16
Pages: 83
Cardiopulmonary Bypass Equipment is a device used in open heart surgery to support the body during the surgical procedure while the heart is stopped. The Cardiopulmonary Bypass Equipment is also called a heart-lung machine. The heart-lung machine is often referred to as the “pump”, and does the work of the heart and lungs during the operation.
Published: 2024-04-17
Pages: 146
Cardiopulmonary Bypass Equipment is a device used in open heart surgery to support the body during the surgical procedure while the heart is stopped. The Cardiopulmonary Bypass Equipment is also called a heart-lung machine. The heart-lung machine is often referred to as the “pump”, and does the work of the heart and lungs during the operation.
Published: 2024-04-16
Pages: 123
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
WHY THIS REPORT
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now